title: Gefitinib-associated Propionibacterium acnes pleural empyema.
authors.forename: Nicolas
authors.initials: N
authors.lastname: de Prost
authors.forename: Armelle
authors.initials: A
authors.lastname: Lavolé
authors.forename: Laurent
authors.initials: L
authors.lastname: Taillade
authors.forename: Marie
authors.initials: M
authors.lastname: Wislez
authors.forename: Jacques
authors.initials: J
authors.lastname: Cadranel
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis / Q000628:therapy; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016724:Empyema, Pleural / Q000382:microbiology* / Q000628:therapy; D005260:Female; D000077156:Gefitinib; D016908:Gram-Positive Bacterial Infections / Q000382:microbiology* / Q000628:therapy; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000628:therapy; D008875:Middle Aged; D018700:Pleurodesis; D011425:Propionibacterium acnes; D011799:Quinazolines / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib